Metabolomics biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis
Clinica Chimica Acta · 2026-06 · 588 · 120940
DOI: 10.1016/j.cca.2026.120940 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinica Chimica Acta, 2026-06. Verfasst von Yuhong He und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Disaster and Emergency Medicine, Tianjin University, Tianjin, China; Tianjin Key Laboratory of Disaster Medicine Technology, Tianjin, China…. Hauptthemen laut MEDLINE: Metabolomics, Respiratory Distress Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 81 Literaturangaben. Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
BACKGROUND Acute respiratory distress syndrome (ARDS) is a severe condition with high mortality, despite the absence of metabolomics biomarkers validated for its pathophysiological features. This systematic review and meta-analysis aim to identify robust metabolic ARDS signatures. METHODS Following PRISMA guidelines, we searched PubMed, Embase, Web of Science, OVID, and Cochrane Library up to March 2025. Case-control studies comparing metabolomics profiles between patients with ARDS and those without ARDS were included. Study quality and risk of bias were assessed using the Newcastle-Ottawa Scale and the NTP/OHAT tool. Random-effects meta-analyses of standardized mean differences were performed with subgroup and sensitivity analyses, while pathway enrichment was conducted as a separate component of the biological evaluation. RESULTS Phenylalanine and lactate levels were elevated in ARDS patients, whereas sphingosine 1-phosphate and citrulline were depleted. Pathway analysis reveals eight disrupted networks, including arginine biosynthesis and glyoxylate metabolism, with "amino acids/peptides" driving the predominant alterations. CONCLUSION This study illustrates metabolic reprogramming as a hallmark of ARDS pathogenesis, linking amino acid and lipid imbalances to inflammation and vascular dysfunction. The findings emphasise the importance of platform harmonization and the potential of biomarker research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Disaster and Emergency Medicine, Tianjin University, Tianjin, China; Tianjin Key Laboratory of Disaster Medicine Technology, Tianjin, China; Wenzhou Safety (Emergency) Institute, Tianjin University, Wenzhou, Z…
- Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
- Disaster Medicine Research Center, Medical Innovation Research Division of the Chinese PLA General Hospital, Beijing 100853, China; 2021RU006 Research Unit of Disaster Medicine, Chinese Academy of Medical Sciences, Beij…
Förderung
- National Key Research and Development Program of China
Zitieren
APA
He, Y., Liu, H., Li, W., Yu, Y., Lin, H., Shi, S., Lu, M., Luo, H., Li, X., & Guo, L. (2026). Metabolomics biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis. Clinica Chimica Acta, 588, 120940. https://doi.org/10.1016/j.cca.2026.120940
Vancouver
He Y, Liu H, Li W, Yu Y, Lin H, Shi S, et al. Metabolomics biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis. Clinica Chimica Acta. 2026;588:120940. doi:10.1016/j.cca.2026.120940
BibTeX
@article{He2026,
author = {He, Yuhong and Liu, Hongxuan and Li, Weixia and Yu, Yuanyuan and Lin, Huishu and Shi, Shuhao and Lu, Mengwei and Luo, Hui and Li, Xiaoxue and Guo, Liqiong},
title = {Metabolomics biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis},
journal = {Clinica Chimica Acta},
year = {2026},
volume = {588},
pages = {120940},
doi = {10.1016/j.cca.2026.120940}
}
EUVIMED